KYMR in the 13F filings
Kymera Therapeutics Inc · CUSIP 501575104
- Quarter end
- 31 Mar 2024
- the date the book describes
- Filed
- 15 May 2024
- latest of these filings; the earliest 15 May 2024
- Managers listing it
- 6
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q4 2023 and Q1 2024; 3 listed it in both
- Shares listed
- 12,347,521
- combined, among listed positions
- Reported value
- $496m
- combined, at the quarter end
Among the 93 comparable managers: 4 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing KYMR in Q1 2024
6 of 6 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| T. Rowe Price Associates Inc | 6,332,012 | $255m | under 0.1% | Added | +996,300 | 15 May 2024 (the filing on sec.gov) |
| Wellington Management Group LLP | 4,293,697 | $173m | under 0.1% | Trimmed | n.a. | 15 May 2024 (the filing on sec.gov) |
| Marshall Wace LLP | 572,926 | $23m | under 0.1% | New | new | 15 May 2024 (the filing on sec.gov) |
| Woodline Partners LP | 500,930 | $20m | 0.19% | Added | +400,179 | 15 May 2024 (the filing on sec.gov) |
| Schonfeld Strategic Advisors LLC | 380,442 | $15m | 0.10% | Trimmed | -57,191 | 15 May 2024 (the filing on sec.gov) |
| Voloridge Investment Management LLC | 267,514 | $11m | under 0.1% | Added | n.a. | 15 May 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 6,332,012 shares now+996,300
- Marshall Wace LLPnew position · 572,926 shares now+572,926
- Woodline Partners LPexisting position · 500,930 shares now+400,179
Reductions
- Schonfeld Strategic Advisors LLCexisting position · 380,442 shares now-57,191
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2020 | 2 | $8.3m | n.a. | n.a. |
| Q4 2020 | 1 | $11m | n.a. | n.a. |
| Q2 2021 | 1 | $1.8m | n.a. | n.a. |
| Q3 2021 | 1 | $7.6m | n.a. | n.a. |
| Q4 2021 | 1 | $171m | n.a. | n.a. |
| Q1 2022 | 2 | $30m | n.a. | n.a. |
| Q2 2022 | 1 | $2.0m | n.a. | n.a. |
| Q3 2022 | 1 | $2.2m | n.a. | n.a. |
| Q4 2022 | 3 | $226m | n.a. | n.a. |
| Q1 2023 | 3 | $268m | n.a. | n.a. |
| Q2 2023 | 1 | $2.5m | n.a. | n.a. |
| Q3 2023 | 1 | $1.4m | n.a. | n.a. |
| Q4 2023 | 3 | $150m | 2 | 1 |
| Q1 2024 | 6 | $496m | 4 | 2 |
| Q2 2024 | 4 | $343m | 3 | 1 |
| Q3 2024 | 5 | $582m | 3 | 2 |
| Q4 2024 | 6 | $536m | 5 | 1 |
| Q1 2025 | 4 | $372m | 2 | 3 |
| Q2 2025 | 5 | $615m | 3 | 2 |
| Q3 2025 | 6 | $737m | 2 | 3 |
| Q4 2025 | 7 | $1.7bn | 15 | 12 |
| Q1 2026 | 8 | $2.1bn | 12 | 15 |
| Q2 2026 | 8 | $3.0bn | 12 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
KYMR and GILD →KYMR and AMGN →KYMR and ARGX →Choose a stock to compare with KYMR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own KYMR, latest filings →Back to the 13F Explorer →